BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 23174488)

  • 1. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
    Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
    Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines.
    Terra X; Auguet T; Quesada I; Aguilar C; Luna AM; Hernández M; Sabench F; Porras JA; Martínez S; Lucas A; Pellitero S; Llutart J; del Castillo D; Richart C
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):691-8. PubMed ID: 22182404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.
    Moschen AR; Molnar C; Wolf AM; Weiss H; Graziadei I; Kaser S; Ebenbichler CF; Stadlmann S; Moser PL; Tilg H
    J Hepatol; 2009 Oct; 51(4):765-77. PubMed ID: 19664840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women.
    Terra X; Auguet T; Broch M; Sabench F; Hernández M; Pastor RM; Quesada IM; Luna A; Aguilar C; del Castillo D; Richart C
    Obesity (Silver Spring); 2013 Jan; 21(1):170-7. PubMed ID: 23505183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
    Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
    Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
    Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
    Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
    Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
    Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.
    Kukla M; Ciupińska-Kajor M; Kajor M; Wyleżoł M; Żwirska-Korczala K; Hartleb M; Berdowska A; Mazur W
    Pol J Pathol; 2010; 61(3):147-53. PubMed ID: 21225497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.
    Kahraman A; Sowa JP; Schlattjan M; Sydor S; Pronadl M; Wree A; Beilfuss A; Kilicarslan A; Altinbaş A; Bechmann LP; Syn WK; Gerken G; Canbay A
    Clin Sci (Lond); 2013 Oct; 125(8):391-400. PubMed ID: 23627434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of lipocalin 2 in adipose tissues of severely obese women: positive relationship with proinflammatory cytokines.
    Auguet T; Quintero Y; Terra X; Martínez S; Lucas A; Pellitero S; Aguilar C; Hernández M; del Castillo D; Richart C
    Obesity (Silver Spring); 2011 Dec; 19(12):2295-300. PubMed ID: 21455126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women.
    Tsiotra PC; Tsigos C; Yfanti E; Anastasiou E; Vikentiou M; Psarra K; Papasteriades C; Raptis SA
    Horm Metab Res; 2007 Oct; 39(10):758-63. PubMed ID: 17952840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.
    Genc H; Dogru T; Kara M; Tapan S; Ercin CN; Acikel C; Karslioglu Y; Bagci S
    Ann Hepatol; 2013; 12(4):548-55. PubMed ID: 23813132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines and cytokines in non-alcoholic fatty liver disease.
    Jarrar MH; Baranova A; Collantes R; Ranard B; Stepanova M; Bennett C; Fang Y; Elariny H; Goodman Z; Chandhoke V; Younossi ZM
    Aliment Pharmacol Ther; 2008 Mar; 27(5):412-21. PubMed ID: 18081738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
    Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
    Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease.
    Auguet T; Terra X; Quintero Y; Martínez S; Manresa N; Porras JA; Aguilar C; Orellana-Gavaldà JM; Hernández M; Sabench F; Lucas A; Pellitero S; Del Castillo D; Richart C
    Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):119-24. PubMed ID: 23426707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visfatin expression is elevated in normal human pregnancy.
    Morgan SA; Bringolf JB; Seidel ER
    Peptides; 2008 Aug; 29(8):1382-9. PubMed ID: 18524416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women.
    Terra X; Quintero Y; Auguet T; Porras JA; Hernández M; Sabench F; Aguilar C; Luna AM; Del Castillo D; Richart C
    Eur J Endocrinol; 2011 Apr; 164(4):539-47. PubMed ID: 21257725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.
    Pagano C; Soardo G; Pilon C; Milocco C; Basan L; Milan G; Donnini D; Faggian D; Mussap M; Plebani M; Avellini C; Federspil G; Sechi LA; Vettor R
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1081-6. PubMed ID: 16394091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children.
    Ooi SQ; Chan RM; Poh LK; Loke KY; Heng CK; Chan YH; Gan SU; Lee KO; Lee YS
    Pediatr Obes; 2014 Apr; 9(2):81-91. PubMed ID: 23447513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.